We are live on ! Find out more
CCA

Conestoga Capital Advisors Portfolio holdings

AUM $4.6B
1-Year Est. Return 16.08%
This Fund
S&P 500
This Quarter Est. Return
+7.66%
1 Year Est. Return
+16.08%
3 Year Est. Return
+47.77%
5 Year Est. Return
+64.2%
10 Year Est. Return
+537.86%
AUM
$6.77B
AUM Growth
+$138M
Cap. Flow
-$225M
Cap. Flow %
-3.33%
Top 10 Hldgs %
34.85%
Holding
126
New
3
Increased
33
Reduced
62
Closed
4

Top Buys

Rank Stock Value
1
BFAM icon
Bright Horizons
BFAM
+$66.4M
2
ULS icon
UL Solutions
ULS
+$30M
3
NOVT icon
Novanta
NOVT
+$26.1M
4
CCC
CCC Intelligent Solutions
CCC
+$18.6M
5
VERX icon
Vertex
VERX
+$17.1M

Top Sells

Rank Stock Value
1
JBTM
JBT Marel
JBTM
+$87.7M
2
ROAD icon
Construction Partners
ROAD
+$76.7M
3
NEOG icon
Neogen
NEOG
+$74M
4
SLP icon
Simulations Plus
SLP
+$37.2M
5
RBC icon
RBC Bearings
RBC
+$32.7M

Sector Composition

Rank Sector Weight
1 Industrials 41.49%
2 Technology 32.06%
3 Healthcare 13.29%
4 Materials 6.31%
5 Real Estate 3.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERII icon
76
Energy Recovery
ERII
$443M
$1.44M 0.02%
112,420
+22,895
+26% +$310K
KIDS icon
77
OrthoPediatrics
KIDS
$595M
$1.43M 0.02%
66,588
+12,795
+24% +$277K
BLFS icon
78
BioLife Solutions
BLFS
$1.7B
$1.4M 0.02%
65,017
MSFT icon
79
Microsoft
MSFT
$3.71T
$1.35M 0.02%
2,707
-5
-0.2% -$2.17K
CSGP icon
80
CoStar Group
CSGP
$12.3B
$1.25M 0.02%
15,490
-5
-0% -$389
WCN
81
Waste Connections
WCN
$42B
$1.21M 0.02%
6,464
-20
-0.3% -$3.85K
USPH icon
82
US Physical Therapy
USPH
$1.22B
$1.17M 0.02%
14,965
COST icon
83
Costco
COST
$420B
$1.05M 0.02%
1,060
-5
-0.5% -$4.97K
TWST icon
84
Twist Bioscience
TWST
$7.25B
$1.04M 0.02%
+28,390
New +$981K
ROP icon
85
Roper Technologies
ROP
$39.8B
$986K 0.01%
1,739
-15
-0.9% -$8.48K
SSTI icon
86
SoundThinking
SSTI
$103M
$981K 0.01%
75,110
TKNO icon
87
Alpha Teknova
TKNO
$347M
$944K 0.01%
192,274
CPRT icon
88
Copart
CPRT
$27.5B
$928K 0.01%
18,911
+20
+0.1% +$1.12K
IDXX icon
89
Idexx Laboratories
IDXX
$46.2B
$903K 0.01%
1,684
-10
-0.6% -$4.78K
VEEV icon
90
Veeva Systems
VEEV
$37.4B
$881K 0.01%
3,059
-15
-0.5% -$3.72K
CYRX icon
91
CryoPort
CYRX
$762M
$825K 0.01%
110,557
+39,640
+56% +$246K
SPGI icon
92
S&P Global
SPGI
$120B
$789K 0.01%
1,496
FAST icon
93
Fastenal
FAST
$59.5B
$776K 0.01%
18,480
-90
-0.5% -$3.65K
ANSS
94
DELISTED
Ansys
ANSS
$764K 0.01%
2,176
-401
-16% -$131K
FTNT icon
95
Fortinet
FTNT
$117B
$758K 0.01%
7,173
-3,086
-30% -$311K
IT icon
96
Gartner
IT
$11.7B
$741K 0.01%
1,834
-5
-0.3% -$2.09K
TSCO icon
97
Tractor Supply
TSCO
$18B
$693K 0.01%
13,140
+45
+0.3% +$2.3K
XYL icon
98
Xylem
XYL
$28.1B
$625K 0.01%
4,829
+50
+1% +$6.05K
INTU icon
99
Intuit
INTU
$89B
$610K 0.01%
775
-5
-0.6% -$3.38K
STE icon
100
Steris
STE
$23.1B
$606K 0.01%
2,524
-5
-0.2% -$1.16K

Similar funds

Conestoga Capital Advisors's Q2 2025 Portfolio in Review

As of Q2 2025, Conestoga Capital Advisors held 126 positions worth $6.77B, up 2.1% from $6.63B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Conestoga Capital Advisors withdrew a net $225M in Q2 2025, closing 4 positions and reducing 62 holdings. Its most notable exit was Neogen, an estimated $74M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 41% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Conestoga Capital Advisors opened a new position in Twist Bioscience worth $1.04M.

  • Conestoga Capital Advisors's largest Q2 2025 buy was Twist Bioscience: 28,390 shares worth $1.04M.
  • Conestoga Capital Advisors added most to Bright Horizons in Q2 2025, an estimated $66.4M increase.
  • Conestoga Capital Advisors's biggest Q2 2025 reduction was JBT Marel, cutting an estimated $87.7M.
  • Conestoga Capital Advisors fully exited Neogen in Q2 2025, selling an estimated $74M.
  • Conestoga Capital Advisors's ten largest holdings make up 35% of its $6.77B portfolio in Q2 2025.
  • Conestoga Capital Advisors opened 3 new positions and closed 4 in Q2 2025.
  • Conestoga Capital Advisors's portfolio value rose 2.1% quarter-over-quarter to $6.77B.

Based on Conestoga Capital Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.